Aelian Biotechnology combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. The approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of action in drugs.

www.aelianbio.com